Will Attention by Vaccine Developers to the Host’s Nuclear Hormone Levels and Immunocompetence Improve Vaccine Success?

Despite extraordinary advances in fields of immunology and infectious diseases, vaccine development remains a challenge. The development of a respiratory syncytial virus vaccine, for example, has spanned more than 50 years of research with studies of more than 100 vaccine candidates. Dozens of attra...

Full description

Bibliographic Details
Main Authors: Robert E. Sealy, Bart G. Jones, Sherri L. Surman, Rhiannon R. Penkert, Stephane Pelletier, Geoff Neale, Julia L. Hurwitz
Format: Article
Language:English
Published: MDPI AG 2019-02-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/7/1/26